Literature DB >> 35368807

Skin Rash in a Stage 4 CKD Patient Treated for Hyperkalemia.

Hanna Boge1, Sloan Almehmi2, Ammar Almehmi3.   

Abstract

Entities:  

Keywords:  CKD; chronic kidney disease; chronic renal insufficiency; exanthema; hyperkalemia; patiromer; skin rash

Mesh：

Substances：

Year:  2021        PMID： 35368807      PMCID： PMC8785723          DOI： 10.34067/KID.0003992020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  5 in total

Review 1.  Leucocytoclastic vasculitis: an update for the clinician.

Authors:  P Koutkia; E Mylonakis; S Rounds; A Erickson
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

2.  Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.

Authors:  Matthew R Weir; George L Bakris; David A Bushinsky; Martha R Mayo; Dahlia Garza; Yuri Stasiv; Janet Wittes; Heidi Christ-Schmidt; Lance Berman; Bertram Pitt
Journal:  N Engl J Med       Date:  2014-11-21       Impact factor: 91.245

Review 3.  Patiromer: The First Potassium Binder Approved in Over 50 Years.

Authors:  Betty N Vu; Alyssa Mae De Castro; David Shottland; William H Frishman; Angela Cheng-Lai
Journal:  Cardiol Rev       Date:  2016 Nov/Dec       Impact factor: 2.644

4.  The frequency of hyperkalemia and its significance in chronic kidney disease.

Authors:  Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
Journal:  Arch Intern Med       Date:  2009-06-22

Review 5.  Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia.

Authors:  Lingyun Li; Stephen D Harrison; M Jamie Cope; Craig Park; Lawrence Lee; Faleh Salaymeh; Deidre Madsen; Wade W Benton; Lance Berman; Jerry Buysse
Journal:  J Cardiovasc Pharmacol Ther       Date:  2016-02-07       Impact factor: 2.457
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.